homoharringtonine
Showing 1 - 9 of 9
Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +2 more
-
Suzhou, Jiangsu, ChinaQiu Huiying
Mar 28, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
- (no location specified)
May 29, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 1, 2023
Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)
Not yet recruiting
- Relapsed/Refractory AML
- Selinexor
- +6 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Mar 28, 2023
Acute Myeloid Leukemia Trial in NanJing (Homoharringtonine, Azacitidine)
Recruiting
- Acute Myeloid Leukemia
- Homoharringtonine
- Azacitidine
-
NanJing, ChinaDepartment of Hematology, Zhongda Hospital, Medical School of So
Sep 2, 2022
Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia
- Selinexor
- +5 more
-
Taiyuan, Shanxi, ChinaTao Wang
Feb 9, 2023
Myeloid Leukemia, Chronic, Myeloid Leukemia, Chronic, Accelerated-Phase, Blast Phase Trial in Houston (Homoharringtonine,
Terminated
- Myeloid Leukemia, Chronic
- +3 more
- Homoharringtonine
- Imatinib Mesylate
-
Houston, TexasUniv. of Texas M.D. Anderson Cancer Center
Jan 8, 2015
Leukemia Trial in Houston (homoharringtonine, chemo)
Withdrawn
- Leukemia
- homoharringtonine
- chemotherapy
-
Houston, TexasM. D. Anderson Cancer Center at University of Texas
Mar 21, 2013